Cleared Traditional

K203819 - T2 Alpha Femur Retrograde Nailing System, T2 Alpha Femur Antegrade GT/PF Nailing System, T2 Tibial Nailing System, T2 Femoral System, T2 Supracondylar Nail System (FDA 510(k) Clearance)

Feb 2021
Decision
59d
Days
Class 2
Risk

K203819 is an FDA 510(k) clearance for the T2 Alpha Femur Retrograde Nailing System, T2 Alpha Femur Antegrade GT/PF Nailing System, T2 Tibial Nailing System, T2 Femoral System, T2 Supracondylar Nail System. This device is classified as a Rod, Fixation, Intramedullary And Accessories (Class II - Special Controls, product code HSB).

Submitted by Stryker GmbH (Mahwah, US). The FDA issued a Cleared decision on February 26, 2021, 59 days after receiving the submission on December 29, 2020.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3020.

Submission Details

510(k) Number K203819 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 29, 2020
Decision Date February 26, 2021
Days to Decision 59 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code HSB — Rod, Fixation, Intramedullary And Accessories
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3020

Similar Devices — HSB Rod, Fixation, Intramedullary And Accessories

All 33
Arthrex Humeral Nails
K252016 · Arthrex, Inc. · Mar 2026
Affixus Retrograde Femoral Nailing System
K253566 · Zimmer, Inc. · Mar 2026
Arthrex FibuLock Nail System
K252196 · Arthrex, Inc. · Mar 2026
Phantom® Hindfoot TTC/TC Nail System
K253591 · Paragon 28, Inc. · Mar 2026
T2 Alpha Femur Retrograde Nailing System
K253640 · Stryker GmbH · Feb 2026
ARIX Femur Nail System
K252826 · Jeil Medical Corporation · Dec 2025